MicrobiomeDAO is a decentralized network funding and translating microbiome science into real-world health solutions. We support community-led research, citizen trials, and product validation in gut health and related fields. Our mission is to bridge the gap between science and society by enabling collaborative, open-source research. Our vision is a world where everyone can access, contribute to, and benefit from microbiome discoveries.
$50B
Annual IBD costs in the US; similar burdens exist in EU/Asia. $13,288 median annual healthcare cost per IBS, Crohn’s disease, and ulceritis patient in the US.
$196 Billion
Projected market size by 2030 for probiotics, live biotherapeutics, and multi-omic diagnostics, with an annual growth rate of 14%.
>$1 Billion
Valuation of 180+ microbiome therapies currently progressing through clinical trials, highlighting an urgent demand for rich longitudinal datasets and innovative trial methodologies.
Gut health affects billions, but most solutions lack proof. We fund real science, run fast trials, and turn data into high value, user-owned assets.
The microbiome shapes your mood, immunity, energy, and even lifespan. But research is locked in labs and rarely benefits the people who need it most....
BiomeTwin – AI-Powered Microbiome Twin
Train AI on user-contributed health, diet, and microbiome data to build a “digital twin” that predicts disease risk, treatment response, and optimal interventions. This longitudinal model becomes a personalized simulation engine owned by the user, licensed by partners, and constantly improving via real-world feedback.
BiomeVault – Decentralized Donor Network
Create a global registry of validated microbiome donors for FMT, research, and biobanking. Donor profiles are tokenized and enriched with biometric metadata, enabling secure matching for trials and clinics. This solves the trust, traceability, and access bottlenecks in live biotherapeutic development.
BiomeTrials – Community-Led Research Engine
Launch scalable citizen science trials across multiple conditions: gut-brain, metabolic, skin, and more. By combining real-world data collection (diet, mood, microbiome, wearables) with DAO governance, this platform becomes a low-cost, high-impact alternative to traditional trials, generating IP and longitudinal datasets.
＠microbiomedao on 𝕏
Discord community
Telegram community
MicrobiomeDAO captures value through a circular model that connects research, data, and product innovation. Our biome collective strategically invests into Science projects, consumer public goods, citizen science trials and Moonshot projects that mat...
Frontiers in Cellular and Infection Microbiology
Current Progresses and Challenges in Microbiome Research
The Lancet Gastroenterology & Hepatology
International Consensus on Microbiome Testing in Clinical Practice
Gastroenterology
